Investigational Drug Information for Drotaverine
✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
What is the drug development status for Drotaverine?
Drotaverine is an investigational drug.
There have been 6 clinical trials for Drotaverine. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2016.
The most common disease conditions in clinical trials are Asphyxia Neonatorum, Asphyxia, and Dilatation, Pathologic. The leading clinical trial sponsors are Changhai Hospital, Ain Shams University, and Ain Shams Maternity Hospital.
Summary for Drotaverine
|US Patent Applications||802|
|WIPO Patent Applications||326|
|Japanese Patent Applications||99|
|Clinical Trial Progress||Phase 3 (2016-05-01)|
Recent Clinical Trials for Drotaverine
|Morphine Versus Ketorolac in Renal Colic||Loredana Ghinea||Phase 4|
|The Impact of Papaverine on First Stage of Labor||eran ashwal||Phase 3|
|Drotaverine to Shorten the Length of Labor||Ain Shams Maternity Hospital||Phase 2/Phase 3|
Clinical Trial Summary for Drotaverine
Top disease conditions for Drotaverine
Top clinical trial sponsors for Drotaverine
US Patents for Drotaverine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|